HAE Key Stats
- Interesting HAE Put For July 10:08 AM
- Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd., Interviews with ... May 17
- Haemonetics Corporation - Analyst/Investor Day Seeking Alpha May 16
- HAE Crosses Above Key Moving Average Level May 16
- Bargain Hunters Take Note: Insider Cluster-Buying At HAE May 8
- Insiders Buy the Holdings of XSLV May 6
- HAE Beats on Earnings, Revs in Line May 3
- HAE Beats on Earnings, Revs in Line - Analyst Blog Zacks May 3
- HAEMONETICS CORP Files SEC form 8-K/A, Results of Operations and Financial Condi... May 3
- Haemonetics Closes Hemerus Acquisition May 2
HAE Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Haemonetics Corporation is up 17.63% over the last year vs S&P 500 Total Return up 31.64%, Covidien up 25.97%, and NxStage Medical down 10.84%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for HAE
Pro Report PDF for HAE
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download HAE Pro Report PDF
Pro Strategies Featuring HAE
Did Haemonetics Corporation make it into our Pro Portfolio Strategies?